Study: Perimenopause Linked to accelerated Fat Gains; Lean Mass Loss

New findings from the University of California – Los Angeles Health Sciences finds the menopause transition phase, also known as perimenopause, …

Novo Nordisk Seeks U.S. FDA Approval for Oral Type 2 Diabetes Medication

Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for oral semaglutide, …

One Drop Partners With Amazon’s Choice To Expand Health Services Offering

One Drop, a company developing digital therapeutics solutions for people with diabetes and related conditions, today announced a partnership with …

ADA Expands Programs to Address Gaps in Type 2 Diabetes Care

To improve gaps in Type 2 diabetes care within health care systems and to reduce cardiovascular problems for people living with Type 2 diabetes, the …

Aerpio Pharmaceuticals Study for Diabetic Retinopathy Does Not Meet Endpoints

Aerpio Pharmaceuticals, a company focused on developing drugs to treat ocular diseases and diabetic complications, today announced top-line results …

Fractyl Labs Initiates U.S. Trial of Outpatient Procedural Therapy for Type 2 Diabetes

Fractyl Laboratories, a private medical technology company based in Lexington, Mass. has started the company’s first U.S. clinical trial for its …

Diabetes drug effective against heart failure in wide spectrum of patients

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with …

Study: Mentally Tiring Work May Increase Diabetes Risk in Women

Women who find their jobs mentally tiring are more likely to develop Type 2 diabetes, according to a study published in the European Journal of …

Study: Green Tea Cuts Obesity, Health Risks in Mice

By: Misti Crane Green tea cut obesity and a number of inflammatory biomarkers linked with poor health in a new study. Mice fed a diet of 2 percent …

POPS! Diabetes Care Announces the Commercial Launch of Their New System

POPS! Diabetes Care announced the commercial launch of their POPS!® one diabetes management system following FDA clearance in November. …